Position
Chief Financial Officer
Company
Actio Biosciences
San DiegoBiotechnologyHealth CareTherapeuticsDescription
Actio Biosciences has appointed Cayce Denton as chief financial officer. Ms. Denton brings over two decades of experience in finance, strategy, and business development within the biotech and pharmaceutical industries, most recently serving as general partner at Dandelion Capital Management.
Quick answer
Actio Biosciences Appoints Cayce Denton as Chief Financial Officer (January 8, 2025). Actio Biosciences is based in San Diego, California, United States.
- Who is the new Chief Financial Officer at Actio Biosciences?
- Actio Biosciences named Cayce Denton Chief Financial Officer, announced January 8, 2025.
- What did Actio Biosciences announce on January 8, 2025?
- Actio Biosciences has appointed Cayce Denton as chief financial officer. Ms. Denton brings over two decades of experience in finance, strategy, and business development within the biotech and pharmaceutical industries, most recently serving as general partner at Dandelion Capital Management.
- What does Actio Biosciences do?
- Actio Biosciences is a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases.
- Where is Actio Biosciences based?
- Actio Biosciences is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- Noema Pharma (January 8, 2025), Centessa Pharmaceuticals plc (January 8, 2025), AiCuris Anti-infective Cures AG (January 8, 2025) and GEMMABio (January 9, 2025) also announced leadership changes within 45 days of Actio Biosciences.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Noema Pharma Appoints Michael Samar as Chief Financial Officer and Volker Knappertz as Executive Vice President of Research and Development (January 8, 2025)
- Centessa Pharmaceuticals plc Appoints Stephen Kanes MD PhD as Chief Medical Officer (January 8, 2025)
- Aicuris Appoints Jacques Dumas, Ph.D., as Chief Scientific Officer (January 8, 2025)
- GEMMABio Appoints May Orfali, MD, MBA, as Chief Medical Officer (January 9, 2025)
- MitoRx Therapeutics Appoints Dr. Lubor Gaal as Chief Business Officer and Stacey Massey as Finance Director (January 9, 2025)
- Nimbus Therapeutics appoints Peter J. Tummino, Ph.D. as President of Research and Development (January 9, 2025)
Who to call at Actio Biosciences, and when
A new leader at Actio Biosciences brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Actio Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Actio Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Actio Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Actio Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Actio Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.